The anti-idiotypic antibody 4B5 (mimicking ganglioside GD2) for diagnosis and therapy of cancer

Author：

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.10, Iss.2, 2000-02, pp. : 255-257

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-GD2 Antibody Therapy for GD2-Expressing Tumors

Current Cancer Drug Targets, Vol. 10, Iss. 2, 2010-03 ,pp. : 200-209

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer

By Yeon Christina Pegram Mark

Investigational New Drugs, Vol. 23, Iss. 5, 2005-10 ,pp. : 391-409

Springer Publishing Company

Access to resources Recommend Favorite

Biotechnological Approaches to the Production of Idiotypic Vaccines and Antiidiotypic Antibiotics

Current Pharmaceutical Biotechnology, Vol. 4, Iss. 2, 2003-04 ,pp. : 91-97

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-HER2 Cancer Therapy and Cardiotoxicity

Current Pharmaceutical Design, Vol. 20, Iss. 30, 2014-09 ,pp. : 4911-4919

Bentham Science Publishers

Access to resources Recommend Favorite

Antibody-based cancer therapy

By Baxevanis Constantin N

Expert Opinion on Drug Discovery, Vol. 3, Iss. 4, 2008-04 ,pp. : 441-452

Informa Healthcare

Access to resources Recommend Favorite